The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.

ABSTRACT:

Introduction

While Lyme disease (LD) is mostly treatable, misdiagnosed or untreated LD can result in debilitating sequelae and excessive healthcare usage. The objective of this review was to characterize the body of literature on the economic burden of Lyme disease (LD) and the cost-effectiveness of LD interventions, such as antibiotic treatment and vaccination.

Methods

We followed Joanna Briggs Institute scoping review methodologies. We systematically searched terms related to LD, economic evaluations, costs, and cost-effectiveness in Medline, Embase, PsycInfo, Cochrane Library, and the grey literature up to November 2017. We included primary economic evaluations conducted in North America and Europe, reporting LD-related costs or cost-effectiveness of human interventions.

SUBMITTER: Mac S 

PROVIDER: S-EPMC6319811 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature